文献速递临床试验与 GCP

血管生成因子与母胎多普勒超声对足月胎儿生长受限的比较:一项开放标签随机对照试验

Angiogenic factors versus fetomaternal Doppler for fetal growth restriction at term: an open-label, randomized controlled trial.
PubMed 文献 · Nat Med · 2025-01-07

这项开放标签随机对照试验纳入1088例单胎妊娠孕妇,随机分配至基于多普勒超声(对照组)或基于sFlt-1:PlGF(干预组)的管理方案,主要结局在1013例中评估。干预组主要结局发生率为10.5%,对照组为10.0%,绝对差异0.53(-3.21至4.26),置信区间上限小于8.5%,证实非劣效性。

要点

  • 对36周后的小于胎龄胎儿,基于sFlt-1:PlGF的方案在避免新生儿酸中毒或异常胎心监护所致剖宫产方面不劣于基于EFW和多普勒超声的方案。
  • 置信区间上限小于预设的非劣效界值8.5%。

核心结论

  • 在36周后的小胎儿中,基于sFlt-1:PlGF的管理方案在避免新生儿酸中毒或因胎心监护异常而行剖宫产方面不劣于基于EFW和多普勒超声的方案。

研究设计与样本

  • 开放标签随机对照试验,纳入1088例单胎妊娠孕妇,随机分配至基于多普勒超声的对照组或基于sFlt-1:PlGF的干预组,主要结局在1013例参与者中评估。

主要发现

  • 置信区间上限小于8.5%,证实非劣效性。

关键数值与推荐

  • 非劣效界值为置信区间上限小于8.5%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Small fetuses, with estimated fetal weight (EFW) below the tenth percentile, are classified as fetal growth restriction (FGR) or small for gestational age (SGA) based on prenatal ultrasound. FGR fetuses have a greater risk of stillbirth and perinatal complications and may benefit from serial ultrasound scans to guide early delivery. Abnormal serum angiogenic factors, such as the soluble fms-like tyrosine kinase-1 (sFlt-1):placental growth factor (PlGF) ratio, have shown potential to more accurately distinguish FGR from SGA, with fewer false positives. This randomized controlled trial compared a management protocol based on the sFlt-1:PlGF with EFW and Doppler ultrasound in avoiding adverse perinatal outcomes in small fetuses after 36 weeks of gestation. A total of 1,088 pregnant women with singleton pregnancies were randomized to either the Doppler-based (control) or the sFlt-1:PlGF-based (intervention) protocol. The primary outcome, neonatal acidosis or Cesarean delivery as a result of abnormal cardiotocography, was assessed in 1,013 participants. The incidence was 10.5% in the intervention group and 10.0% in the control group (absolute difference, 0.53 (-3.21 to 4.26)), with the upper limit of the confidence interval <8.5%, confirming noninferiority. Thus, the sFlt-1:PlGF was noninferior to EFW and Doppler ultrasound in avoiding neonatal acidosis or Cesarean delivery owing to nonreassuring fetal status in small fetuses after 36 weeks (ClinicalTrials.gov registration: NCT04502823 ).

来源:Nat Med,查看原文。版权归原作者所有。

引用

  1. Garcia-Manau P, Bonacina E, Martin-Alonso R, et al. Angiogenic factors versus fetomaternal Doppler for fetal growth restriction at term: an open-label, randomized controlled trial. Nat Med. 2025. PMID: 39775039. doi:10.1038/s41591-024-03421-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。